Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Obesity
Clinical trial register · Brazil

Obesity Trials in Brazil, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Brazil and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2233 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:18 UTC
2233
Studies in scope
all four open statuses
1129
Recruiting now
open to new participants
355
Lead sponsors
across recruiting studies
Top sites
Campinas 14 Porto Alegre 13 São Paulo 12 Curitiba 11 Brasília 7
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Eli Lilly and Company10 Novo Nordisk A/S6 University of Sao Paulo3 Amgen3 Pfizer1 Kaiser Clinic and Hospital1 Universidade Federal de Pernambuco1 Hospital de Clinicas de Porto Alegre1 Laboratorio de Vibraçoes Mecanicas e Praticas Integrativas1 Raquel Ballarin1 Clinica Gastrobese1
Site location
Campinas14 Porto Alegre13 São Paulo12 Curitiba11 Brasília7 Fortaleza7 Rio de Janeiro7 Vitória5 Goiânia5 Belo Horizonte4 Recife4 Bragança Paulista3 Marília3 Ribeirão Preto2 Salvador2 Uberlândia2 Botucatu2 Santo André2 Aracaju2 São José do Rio Preto1 Campo Grande1 Bauru1 Caxias do Sul1 Manaus1 Bairro Rodolfo Teófilo, Fortaleza1 Show all 35
All 35 locations
Target enrolment
to

Obesity trials in Brazil

29 of 2233 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Brazil
Start
Not yet open
Eli Lilly and Company
Phase 3
3,000
Aracaju, Brasília, Campinas, Curitiba, Fortaleza, Porto Alegre, Recife, Rio de Janeiro
2026-12
Not yet open
Novo Nordisk A/S
Phase 3
1,408
Belo Horizonte, Curitiba, Bragança Paulista, Campinas, São Paulo
2026-11-11
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Manaus, Bairro Rodolfo Teófilo, Fortaleza, Goiânia, Poços de Caldas, Curitiba, Porto Alegre, Botucatu, Bragança Paulista
2026-10-26
Recruiting
Eli Lilly and Company
Phase 3
1,000
Campinas, Curitiba, Porto Alegre, Rio de Janeiro, São Paulo
2026-10-16
Recruiting
Pfizer
Phase 3
954
Brasília, Campinas, São José do Rio Preto, São Paulo
2026-06-10
Active, closed
Novo Nordisk A/S
Phase 3
985
Porto Alegre, Campinas, São Paulo
2026-05-20
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Rio Branco, Maceió, Belo Horizonte, Uberlândia, Recife, Porto Alegre, Blumenau, Bragança Paulista
2026-05-11
Active, closed
Novo Nordisk A/S
Phase 3
638
Curitiba, Campinas, São Paulo
2026-04-13
Active, closed
University of Sao Paulo
Not applicable
60
Ribeirão Preto
2026-03-01
Recruiting
Eli Lilly and Company
Phase 3
900
Curitiba, Fortaleza, São Paulo, Vitória, Votuporanga
2026-02-10
Recruiting
Eli Lilly and Company
Phase 3
800
Campinas, Marília, Porto Alegre, Recife, Rio de Janeiro, Santo André, São Paulo
2026-02-10
Recruiting
Eli Lilly and Company
Phase 3
1,980
Brasília, Campinas, Fortaleza, Marília, Porto Alegre, Rio de Janeiro, São Paulo
2026-02-06
Active, closed
Amgen
Phase 3
250
Porto Alegre, Campinas, São Paulo
2025-12-19
Active, closed
Amgen
Phase 3
12,800
Fortaleza, Vitória, Salvador, Brasília, Goiânia, Campo Grande, Belo Horizonte, Uberlândia
2025-07-25
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Vitória, Salvador, Goiânia, Belo Horizonte, Curitiba, Porto Alegre, Aracaju, Campinas
2025-06-25
Not yet open
Proteomic Analysis of Patients Undergoing Bariatric Surgery
NCT06787807Obesity, Colon Cancer, Thyroid Cancer, Esophageal Cancer
Universidade Federal de Pernambuco
Not applicable
103
Recife
2025-06-10
Active, closed
Eli Lilly and Company
Phase 3
465
Brasília, Campinas, Curitiba, Goiânia, Porto Alegre, Rio de Janeiro, São Paulo
2025-05-12
By invitation
Novo Nordisk A/S
Not applicable
36,000
Campinas
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
905
Curitiba, Fortaleza, Goiânia, São Paulo, Vitória
2025-04-25
Active, closed
University of Sao Paulo
Not applicable
50
Ribeirão Preto
2025-03-01
Recruiting
Raquel Ballarin
Not applicable
15
Botucatu
2025-01-15
Recruiting
Kaiser Clinic and Hospital
Not applicable
30
Santo André
2025-01
Recruiting
Eli Lilly and Company
Phase 3
125
Brasília, Caxias do Sul, São Paulo
2024-11-18
Recruiting
University of Sao Paulo
Not applicable
24
Bauru
2023-10-09
Active, closed
Eli Lilly and Company
Phase 3
3,127
Fortaleza, Vitória, Bequimão, Curitiba, Porto Alegre, Campinas, Jaú, São Bernardo do Campo
2023-06-05
Active, closed
Impact of GEA Simultaneous to VSG on Post-operative GERD
NCT07537244Obesity, Reflux, Gastroesophageal
Clinica Gastrobese
Not applicable
60
Passo Fundo
2023-02-18
Recruiting
Hospital de Clinicas de Porto Alegre
Not applicable
146
Porto Alegre
2022-11-01
Active, closed
Eli Lilly and Company
Phase 3
15,374
Brasília, Campinas, Curitiba, Fortaleza, Marília, Niterói, Porto Alegre, Rio de Janeiro
2022-10-11
Recruiting
Laboratorio de Vibraçoes Mecanicas e Praticas Integrativas
Not applicable
90
Rio de Janeiro
2021-03-05
Rows per page Showing 1–29 of 29
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Brazilian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-brazil/condition/obesity

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Brazil and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,233 studies in total at the last sync on 12 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 29 of those studies listing the condition Obesity.

How many Obesity trials are recruiting in Brazil?

13 of the 29 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:18 UTC sync. A further 4 have not yet opened recruitment, 11 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Obesity), 29 studies
PhaseStudiesRecruitingShare
Phase 319865.5%
Not applicable10534.5%

Most active sponsors

Lead sponsors with the most studies (Obesity)
Lead sponsorStudiesRecruiting
Eli Lilly and Company105
Novo Nordisk A/S61
Amgen31
University of Sao Paulo31
Clinica Gastrobese10
Hospital de Clinicas de Porto Alegre11
Kaiser Clinic and Hospital11
Laboratorio de Vibraçoes Mecanicas e Praticas Integrativas11
Pfizer11
Raquel Ballarin11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.